Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

NCT00117884 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
240
Enrollment
INDUSTRY
Sponsor class

Stopped Lack of efficacy

Conditions

Interventions

Sponsor

Takeda